New Zealand's Medsafe Approves First Medicine via Rule of Two Pathway: Paliperidone
New Zealand Associate Health Minister David Seymour announced in Wellington on November 12, 2026, that paliperidone has become the first medicine approved in New Zealand via the expedited Rule of Two pathway, with the approval granted by Medsafe, the country's medicines regulator.
The Rule of Two is an accelerated approval route under which medicines already approved by two recognised overseas regulators can undergo a streamlined assessment in New Zealand, shortening the time for new medicines to reach the local market. Paliperidone, a treatment for schizophrenia, is the first approval under the pathway.
Seymour, the Associate Minister of Health, announced the first approval in a government release published on the Beehive platform the same day. (Source: New Zealand Government)
Source: New Zealand Government
Published by GSM · USA (original Chinese edition)
Photo: 图：新西兰议会大厦（惠灵顿）。照片：Tom Ackroyd，CC BY-SA 4.0，经 Wikimedia Commons。 / New Zealand Parliament Buildings in Wellington. Photo by Tom Ackroyd, CC BY-SA 4.0, via Wikimedia Commons.
